Ultra Market Research | Global Psoriatic Arthritis Market
Global Psoriatic Arthritis Market
Report ID : 769
Category : Therapeutic-Area
No Of Pages : 120
Published on: October 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Psoriatic Arthritis Market
Introduction The Global Psoriatic Arthritis Market revolves around treatments and therapies aimed at managing psoriatic arthritis, a chronic autoimmune disease affecting the skin and joints. This condition causes painful inflammation, joint stiffness, and skin issues, often progressing over time. The market caters to pharmaceuticals, biologics, and advanced therapies designed to reduce inflammation, slow disease progression, and improve patients' quality of life. Recent trends in the Global Psoriatic Arthritis Market highlight a shift toward biologics, biosimilars, and advanced therapeutics, with pharmaceutical companies focusing on innovative treatment approaches. Key players are working on personalized medicine, leveraging novel drug-delivery systems to enhance patient outcomes. Additionally, digital health tools such as mobile applications for remote patient monitoring and disease management have gained traction, influencing the overall growth of the Global Psoriatic Arthritis Market.
Segmentation
The Global Psoriatic Arthritis Market is segmented based on drug class, treatment type, distribution channel, and region.
Large Hospitals Medium Hospitals Others Retail Pharmacies Online Pharmacies Specialty Clinics Others
By Geography North America U.S. Canada
Europe Germany France United Kingdom Rest of Europe
Asia Pacific China Japan India Southeast Asia Rest of Asia Pacific
Latin America Brazil Rest of Latin America
Middle East & Africa (MEA) GCC North Africa South Africa Rest of Middle East & Africa
List of Market Players
AbbVie Inc. (USA) Amgen Inc. (USA) Johnson & Johnson (USA) Novartis AG (Switzerland) Pfizer Inc. (USA) Eli Lilly and Company (USA) Bristol-Myers Squibb (USA) UCB S.A. (Belgium) Celgene Corporation (USA) Biogen (USA) Sanofi S.A. (France) Sun Pharmaceutical Industries Ltd. (India) Merck & Co., Inc. (USA) Gilead Sciences, Inc. (USA) Takeda Pharmaceutical Company (Japan)
Drivers Several key factors are driving the Global Psoriatic Arthritis Market's growth. Firstly, the rising prevalence of psoriatic arthritis, which affects millions globally, is a significant factor. As autoimmune diseases become more prevalent, the demand for innovative treatments increases. Secondly, advancements in biologic drugs have revolutionized the treatment landscape, offering patients relief from symptoms and slowing disease progression. The availability of novel biologics, such as TNF inhibitors and IL-17 inhibitors, provides targeted treatment options. Additionally, increasing patient awareness and early diagnosis through advanced diagnostic tools are contributing to market growth. The growing healthcare infrastructure, particularly in developing countries, and the adoption of telemedicine are also fueling the demand for psoriatic arthritis treatments. Moreover, an aging population is contributing to the rise in psoriatic arthritis cases, further propelling the market.
Restraints Despite growth drivers, the Global Psoriatic Arthritis Market faces several challenges. One significant restraint is the high cost of biologic therapies, which limits patient accessibility, especially in low-income regions. Biologic treatments, which are highly effective, come with substantial costs, creating a financial burden for patients and healthcare systems. Moreover, the side effects associated with long-term use of biologic drugs, including immune system suppression and risk of infections, pose concerns for both patients and healthcare providers. Regulatory hurdles and lengthy approval processes for new therapies also slow market expansion. Additionally, the availability of generic drugs and biosimilars, while offering more affordable treatment options, can impact the profitability of companies developing innovative therapies. Lastly, limited awareness and late diagnosis, particularly in underdeveloped regions, continue to challenge the market.
Opportunities The Global Psoriatic Arthritis Market presents numerous opportunities for growth. Firstly, the rising focus on personalized medicine offers new avenues for targeted treatment approaches. As precision medicine advances, therapies tailored to individual patient needs are expected to gain traction, improving outcomes and reducing adverse effects. Secondly, the introduction of biosimilars in the market offers cost-effective alternatives to expensive biologic therapies, opening up treatment access to a broader patient population. Moreover, untapped markets in developing countries, where the prevalence of psoriatic arthritis is rising, offer immense growth potential. As healthcare infrastructure improves in these regions, demand for effective treatment options will grow. Technological advancements in drug delivery systems, such as self-administered injectables and long-acting medications, also present opportunities for patient convenience and adherence.
Trends Recent trends in the Global Psoriatic Arthritis Market indicate a shift towards the development of advanced biologics and biosimilars. Companies are focusing on creating next-generation biologics that offer improved efficacy with fewer side effects. The market is also witnessing a surge in the adoption of telemedicine and remote monitoring solutions, allowing patients to manage their condition from the comfort of their homes. The integration of artificial intelligence (AI) in drug discovery and development processes is another trend, as it enables pharmaceutical companies to accelerate the creation of new therapies. Furthermore, the increasing focus on combination therapies, which involve using multiple drugs with different mechanisms of action, is expected to enhance treatment outcomes. Lastly, sustainability efforts in drug manufacturing and packaging are becoming more prominent, as companies aim to reduce their environmental footprint.
Key Target Audience
Pharmaceutical Companies Biotech Companies Research Institutes Healthcare Providers Specialty Clinics Hospitals Government Agencies Academic Researchers Investors in Healthcare Regulatory Authorities
FAQs about the Global Psoriatic Arthritis Market
11.7%
Interleukin Inhibitors
The market faces challenges such as the high cost of biologics, regulatory hurdles, and potential side effects of treatments.
North America
Table of Contents
1. Executive Summary 1.1 Global Psoriatic Arthritis Market Overview 1.2 Key Market Trends 1.3 Major Drivers, Restraints, and Opportunities 1.4 Market Outlook and Forecast
2. Introduction 2.1 Definition of Psoriatic Arthritis 2.2 Application in Healthcare 2.3 Recent Market Trends
3. Market Segmentation 3.1 By Drug Type 3.1.1 Biologics 3.1.2 Non-Biologics 3.1.3 Biosimilars 3.2 By Route of Administration 3.2.1 Oral 3.2.2 Injectable 3.2.3 Topical 3.3 By End-User 3.3.1 Hospitals 3.3.2 Specialty Clinics 3.3.3 Home Care 4. Competitive Landscape 4.1 Key Market Players 4.2 Market Share Analysis 4.3 Strategic Developments
5. Market Drivers 5.1 Rising Prevalence of Psoriatic Arthritis 5.2 Advancements in Biologics and Biosimilars 5.3 Growing Awareness and Early Diagnosis
6. Market Restraints 6.1 High Cost of Biologic Therapies 6.2 Regulatory Challenges 6.3 Side Effects of Advanced Treatments
7. Market Opportunities 7.1 Growth of Biosimilars in Emerging Markets 7.2 Research and Development in Immunology 7.3 Adoption of Digital Health Solutions
8. Market Trends 8.1 Increasing Adoption of Biosimilars 8.2 Focus on Combination Therapies 8.3 Integration of Digital Health Tools
10. Frequently Asked Questions (FAQs) 10.1 What is Psoriatic Arthritis? 10.2 What are the Key Drivers? 10.3 What Challenges Does the Market Face? 10.4 What Opportunities Exist in the Market?
List of Tables
Table 1: Global Psoriatic Arthritis Market Overview (2024-2030) Table 2: Global Psoriatic Arthritis Market Segmentation by Drug Type Table 3: Market Segmentation by Route of Administration Table 4: Market Segmentation by End-User Table 5: Competitive Landscape – Major Players in the Global Psoriatic Arthritis Market Table 6: Key Market Drivers for Psoriatic Arthritis Table 7: Market Restraints Impacting Growth Table 8: Growth Opportunities for Psoriatic Arthritis Market Players Table 9: Recent Market Trends in Psoriatic Arthritis Treatment Table 10: Target Audience for Global Psoriatic Arthritis Market Analysis
This structure ensures a professional market research report format, addressing all key sections and tables that are expected in a comprehensive market report.
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Psoriatic Arthritis Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Global Psoriatic Arthritis Market for the past year and forecasts for the next six years. Global Psoriatic Arthritis Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Psoriatic Arthritis Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Psoriatic Arthritis Market from different application industries in different regions.
Segmentation
The Global Psoriatic Arthritis Market is segmented based on drug class, treatment type, distribution channel, and region.
